Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 56, Issue 4, 2007, Pages 571-577

  Ohgushi, Minako ^a   Taniguchi, Ataru ^a   Fukushima, Mitsuo ^b   Nakai, Yoshikatsu ^c   Kuroe, Akira ^a   Ohya, Michihiro ^a   Nagasaka, Shoichiro ^d   Taki, Yoshiro ^a   Yoshii, Satoru ^a   Matsumoto, Kazunari ^e   Yamada, Yuichiro ^c   Inagaki, Nobuya ^c   Seino, Yutaka ^a  

^a KANSAI DENRYOKU HOSPITAL   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e Diabetes Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BEZAFIBRATE; GLICLAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PULSE WAVE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; JAPAN; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33947210223     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.12.007     Document Type: Article

References (51)

1. Bierman E.L. George Lyman Duff memorial lecture. Atherogenesis in diabetes. Arterioacler Thromb 12 (1992) 647-656
2. Woolam G.L., Schnur P.L., Vallbona C., and Hoff H.E. The pulse wave velocity as an early indicator of atherosclerosis in diabetic subjects. Circulation 25 (1962) 533-539
3. Cairns S.A., Woodcock J.P., and Marshall A.J. Early arterial lesions in maturity onset diabetes mellitus detected by an ultrasonic technique. Diabetologia 14 (1978) 107-111
4. Lo C.S., Relf I.R., Myers K.A., and Wahlqvist M.L. Doppler ultrasound recognition of preclinical changes in arterial wall in diabetic subjects: compliance and pulse-wave damping. Diabetes Care 9 (1986) 27-31
5. Cruickshank K., Riste L., Anderson S.G., Wright J.S., Dunn G., and Gosling R.G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 106 (2002) 2085-2090
6. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
7. Kawasaki Y., Taniguchi A., Fukushima M., Nakai Y., Kuroe A., Ohya M., et al. Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients. Horm Metab Res 37 (2005) 617-621
8. Klein N.J., Shennan G.I., Heyderman R.S., and Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin, and neutrophils. J Cell Sci 102 (1992) 821-832
9. Shai I., Schulze M.B., Manson J.E., Rexrode K.M., Stampfer M.J., Mantzoros C., et al. A prospective study of soluble tumor necrosis factor-α receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 28 (2005) 1376-1382
10. Hotamisligil G.S., Shargil N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
11. Tanaka S., Seino H., Satoh J., Fujii N., Rikiishi H., Zyu X.P., et al. Increased in vivo production of tumor necrosis factor after development of diabetes in non-treated, long-term diabetic BB rats. Clin Immunol Immunopathol 62 (1992) 258-263
12. World Health Organization. Diabetes mellitus: Report of a WHO study group (1985), World Health Organization, Geneva (Tech. Rep. Ser., no.727)
13. Friedewald W.T., Levy R.I., and Frederickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-508
14. Matthews D., Hosker J., Rudenski A., Naylor B., Treacher D., and Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
15. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47 (1998) 1643-1649
16. Emoto M., Nishizawa Y., Maekawa K., Hiura Y., Kanda H., Kawagishi T., et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22 (1999) 818-822
17. Taniguchi A., Fukushima M., Sakai M., Kataoka K., Nagata I., Doi K., et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism 49 (2000) 1001-1005
18. Taniguchi A., Fukushima M., Sakai M., Miwa K., Makita T., Nagata I., et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 23 (2000) 1766-1769
19. Nakai Y., Hamagaki S., Takagi R., Taniguchi A., and Kurimoto F. Plasma concentrations of tumor necrosis factor α (TNF-α) and soluble TNF receptors in patients with bulimia nervosa. Clin Endocrinol 53 (2000) 383-388
20. Taniguchi A., Nakai Y., Doi K., Fukuzawa H., Fukushima M., Kawamura H., et al. Insulin sensitivity, insulin secretion, and glucose effectiveness in obese subjects: a minimal model analysis. Metabolism 44 (1995) 1397-1400
21. Kim S.T., Newman A., Simonsick E.M., Havlik R., Pahor M., Lakatta E., et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 38 (2001) 429-435
22. DeFronzo R.A. Lilly lecture 1987. The triumvirate, β-cell, muscle, liver: a collusion responsible for NIDDM. (Review). Diabetes 37 (1988) 667-687
23. Taniguchi A., Nakai Y., Fukushima M., Kawamura H., Imura H., Nagata I., et al. Pathogenic factors responsible for glucose tolerance in patients with NIDDM. Diabetes 41 (1992) 1540-1546
24. Nagasaka K., Tokuyama K., Kusaka I., Hayashi H., Rokkaku K., Nakamura T., et al. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labelled minimal model approach. Diabetes 48 (1999) 1054-1060
25. Taniguchi A., Nakai Y., Tokuyama K., Sakai M., Doi K., Fukushima M., et al. In: Bergman R.N., and Lovejoy L.C. (Eds). Role of glucose effectiveness in the evolution of NIDDM. In the minimal model approach and determinants of glucose tolerance (1997), Louisiana State University Press 357-367
26. Brown B.G., Gallery C.A., Badger R.S., Kennedy J.W., Detlef M., Bolson E.L., et al. Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations. Circulation 92 (1986) 646-656
27. Amar J., Ruidavets J.B., Chamontin B., Drouet L., and Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 19 (2001) 381-387
28. Duprez D.A., Kaiser D.R., Whitwam W., Finkelstein S., Belalcazar A., Patterson R., et al. Determinants of radial artery pulse wave analysis in asymptomatic individuals. Am J Hypertens 17 (2004) 647-653
29. Mahmud A., and Feely J. Effects of passive smoking on blood pressure and aortic pressure waveform in healthy young adults-influence of gender. Br J Clin Pharmacol 57 (2003) 37-43
30. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
31. Tanokuchi S., Okada S., and Ota Z. Factors related to aortic pulse-wave velocity in patients with non-insulin-dependent diabetes mellitus. J Int Med Res 23 (1995) 423-430
32. Okada S., Ishii K., and Hamada H. Relationship between cardiac autonomic neuropathy and diabetic microangiopathy and macroangiopathy in patients with non-insulin-dependent diabetes mellitus. J Int Med Res 24 (1996) 92-98
33. Aso K., Miyata M., Kubo T., Hashiguchi H., Fukudome M., Fukushige E., et al. Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients. Hypertens Res 26 (2003) 807-813
34. Neil A., Hawkins M., Potok M., Thorogood M., Cohen D., and Mann L. Prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16 (1993) 996-1003
35. Rajala U., Pajunpaa H., Koskela P., and Keinanen-Kiukaanniemi S. High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 23 (2000) 957-961
36. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004) 813-823
37. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
38. Duncan B.B., Schmidt M.I., Pankow J.S., Ballantyne C.M., Couper D., Vigo A., et al. Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 52 (2003) 1799-1805
39. Stehouwer C.D.A., Gall M.A., Twisk J.W.R., Knudsen E., Emeis J.J., and Parving H.H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Progressive, interrelated, and independently associated with risk of death. Diabetes 51 (2002) 1157-1165
40. Rader D.J. Inflammatory markers of coronary risk. N Engl J Med 343 (2000) 1179-1182
41. Postlethwaite A.E., and Seyer J.M. Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor α (TNF-α) and a synthetic TNF-α 31-68 peptide. J Exp Med 172 (1990) 1749-1756
42. Camussi G., Albano E., Tetta C., and Bussolino F. The molecular action of tumor necrosis factor-α. Eur J Biochem 202 (1991) 3-14
43. Smith C.A., Farrah T., and Goodwin R.G. TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76 (1994) 959-962
44. Vandenabeele P., Declercq W., Beyaert R., and Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 5 (1995) 392-399
45. Liu L.S., Spelleken M., Rohrig K., Hauner H., and Eckel J. Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes. Implication of the p80 tumor necrosis factor receptor. Diabetes 47 (1998) 515-522
46. Hotamisligil G.S., Arner P., Atkinson R.L., and Spiegelman M. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46 (1997) 451-455
47. Fernandez-Real J.M., Broch M., Ricart W., Casmitjana R., Gutierrez C., Vendrell J., et al. Plasma levels of the soluble fraction of tumor necrosis factor 2 and insulin resistance. Diabetes 47 (1998) 1757-1762
48. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE. A mechanism for amplication of inflammatory responses. Circulation 105 (2002) 816-822
49. Ruits-Ortega M., Lorenzo O., Suzuki Y., Ruperez M., and Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10 (2001) 321-329
50. Sartippour M.R., and Renier G. Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes 49 (2000) 597-602
51. Guha M., Bai W., Nadler J., and Natarajan B.R. Molecular mechanisms of alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress dependent and independent pathways. J Biol Chem 275 (2000) 17728-17735